Company intelligence / Profile preview

Dansk Innovationsinvestering

Copenhagen, Denmark

Ownership: Private
Development stage: Other

Overview

Dansk Innovationsinvestering was a Danish state-owned venture capital firm established to support high-tech and life science innovation in Denmark. The firm played a pivotal role in the early-stage financing of several prominent Danish biotechnology companies, including Genmab and Zealand Pharma. It operated by providing equity capital and strategic guidance to startups emerging from academic research and university spin-outs. Eventually, its activities and portfolio were integrated into Vækstfonden (The Danish Growth Fund), which has since merged into the Export and Investment Fund of Denmark (EIFO).

Industry: Investors

Beyond the preview

Go deeper on Dansk Innovationsinvestering.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dansk Innovationsinvestering.

Explore the full profile